464 results
Page 11 of 24
8-K
jownkiqfdo2hdism7k
2 Feb 11
Discovery Labs Provides Expanded Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
8-K
6prmgms0
10 Jan 11
Discovery Labs Provides Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
DEFA14A
5glcj05r57wc
3 Dec 10
Additional proxy soliciting materials
12:00am
8-K
0a5rnqeb1dn1c
3 Dec 10
Discovery Labs Receives Nasdaq Delisting Notification
12:00am
CORRESP
ku1 t7zl66ehd
10 Nov 10
Correspondence with SEC
12:00am
8-K
kdh2b5i2s39yl7c61 m3
9 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
tz3t3ci6dtp1v6ik
9 Nov 10
Results of Operations and Financial Condition
12:00am
CORRESP
nqrth j9c03ji5n7gx
8 Nov 10
Correspondence with SEC
12:00am
8-K
EX-99.1
l4ocm ib8j6w037e
21 Oct 10
Discovery Labs Appoints W. Thomas Amick as Chief Executive Officer
12:00am
8-K
EX-99.1
i0z1hnzd
13 Oct 10
Entry into a Material Definitive Agreement
12:00am
424B5
bxizva j3mvmrxb8w
13 Oct 10
Prospectus supplement for primary offering
12:00am
CORRESP
bd1eqzxhbbfn0alqkowv
1 Oct 10
Correspondence with SEC
12:00am
8-K
a1nuamjwcv yvsezy2cp
15 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
niu5tbwce uxfv
25 Aug 10
Departure of Directors or Certain Officers
12:00am
8-K
cm43vuoaxe80zt45iroo
25 Aug 10
Departure of Directors or Certain Officers
12:00am
8-K
3hn8 ljflnqmwq8v6
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am